Users online: 1821    [ij] [ij] [ij] 
Email id

Asian Journal of Pharmacy and Technology
Year : 2018, Volume : 8, Issue : 3
First page : ( 145) Last page : ( 148)
Print ISSN : 2231-5705. Online ISSN : 2231-5713.
Article DOI : 10.5958/2231-5713.2018.00023.5

Development and Validation of RP-HPLC Method for Simultaneous Estimation of Saxagliptin and Dapagliflozin in Tablets

More Sayali S., Sonawane Sandeep S.*, Chhajed Santosh S., Kshirsagar Sanjay J.

Department of Pharmaceutical Analysis, MET's Institute of Pharmacy, Bhujbal Knowledge City, Adgaon, Nashik-422 003

*Corresponding Author E-mail: sandeeps.iop@gmail.com

Online published on 24 October, 2018.


A simple, accurate, precise and selective RP-HPLC method was developed and validated for simultaneous estimation of Saxagliptin (SAXA) and Dapagliflozin (DAPA) in tablet dosage form. Both drugs were separated on Phenomenex Hyperclone C18 column (250 ×4.6 mm, 5μ) using methanol: 20 mM phosphate buffer (pH3.0) (70: 30, v/v) in an isocratic mode at flow rate of 1 mL/min. Chromatographic determination was carried out at wavelength of 225nm. SAXA and DAPA were eluted at 4.70 and 6.45min, respectively. The method was found linear in the range of 2–12 μg/mL and 4–24 μg/mL for SAXA and DAPA, respectively. The method was validated for linearity, accuracy, precision and selectivity. The developed method can be used for routine analysis of SAXA and DAPA tablets.



Dapagliflozin, Saxagliptin, HPLC, Analytical Method Validation.


║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
446,690,660 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.